Samil Pharmaceutical Overview
- Year Founded
-
1947
- Status
-
Public
- Employees
-
593
- Stock Symbol
-
000520
- Investments
-
2
- Share Price
-
$7.41
- (As of Tuesday Closing)
Samil Pharmaceutical General Information
Description
Samil Pharmaceutical Co Ltd is engaged in manufacturing and distribution of pharmaceutical products and medicines in South Korea. Its products portfolio consists of gastrointestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives.
Contact Information
Website
www.samil-pharm.comCorporate Office
- Building 3 Floor
- 155 Hyoryeong-ro, Seocho-gu Bangbae-dong
- Seoul, 137-060
- South Korea
Corporate Office
- Building 3 Floor
- 155 Hyoryeong-ro, Seocho-gu Bangbae-dong
- Seoul, 137-060
- South Korea
Samil Pharmaceutical Stock Performance
As of 15-Jul-2025, Samil Pharmaceutical’s stock price is $7.41. Its current market cap is $157M with 21.2M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.41 | $7.35 | $5.86 - $14.43 | $157M | 21.2M | 145K | -$0.45 |
Samil Pharmaceutical Financials Summary
As of 31-Mar-2025, Samil Pharmaceutical has a trailing 12-month revenue of $156M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 260,466 | 287,931 | 205,183 | 195,953 |
| Revenue | 156,058 | 161,018 | 150,175 | 139,055 |
| EBITDA | 1,588 | 6,337 | 7,880 | 7,926 |
| Net Income | (9,296) | (4,125) | 1,272 | (22) |
| Total Assets | 269,272 | 268,214 | 287,643 | 282,443 |
| Total Debt | 107,682 | 101,890 | 136,480 | 126,104 |
Samil Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Samil Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Samil Pharmaceutical Investments (2)
Samil Pharmaceutical’s most recent deal was a Early Stage VC with Singularity Biotech. The deal was made on 01-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Singularity Biotech | 01-Jul-2025 | Early Stage VC | Drug Discovery | ||
| Ybrain | 23-Feb-2022 | Later Stage VC | Therapeutic Devices |
Samil Pharmaceutical FAQs
-
When was Samil Pharmaceutical founded?
Samil Pharmaceutical was founded in 1947.
-
Where is Samil Pharmaceutical headquartered?
Samil Pharmaceutical is headquartered in Seoul, South Korea.
-
What is the size of Samil Pharmaceutical?
Samil Pharmaceutical has 593 total employees.
-
What industry is Samil Pharmaceutical in?
Samil Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Samil Pharmaceutical a private or public company?
Samil Pharmaceutical is a Public company.
-
What is Samil Pharmaceutical’s stock symbol?
The ticker symbol for Samil Pharmaceutical is 000520.
-
What is the current stock price of Samil Pharmaceutical?
As of 15-Jul-2025 the stock price of Samil Pharmaceutical is $7.41.
-
What is the current market cap of Samil Pharmaceutical?
The current market capitalization of Samil Pharmaceutical is $157M.
-
What is Samil Pharmaceutical’s current revenue?
The trailing twelve month revenue for Samil Pharmaceutical is $156M.
-
What is Samil Pharmaceutical’s annual earnings per share (EPS)?
Samil Pharmaceutical’s EPS for 12 months was -$0.45.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
